Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
about
CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancerTumor necrosis factor-alpha induces the aberrant expression of mucus core protein-2 in non-neoplastic biliary epithelial cells via the upregulation of CDX2 in chronic cholangitisDifferent regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race.Relationships between mucinous gastric carcinoma, MUC2 expression and survival.Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.Immunohistochemical biomarkers of value in distinguishing primary ovarian carcinoma from gastric carcinoma: a systematic review with statistical meta-analysis.Gastric mucus alterations associated with murine Helicobacter infection.Utilization of CDX2 expression in diagnosing pancreatic ductal adenocarcinoma and predicting prognosis.Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas.From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases.MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer.Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7.MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis.Expression of MUC2 in gastric carcinomas and background mucosae.
P2860
Q28251382-26FD5FC7-B979-4084-A359-31F0457D5DE8Q28567007-DC14E53A-362A-40B6-822D-F2B18FDB22C5Q33236633-B918E70A-34FE-443F-B409-43D6AE5F018FQ33867941-85B7E479-11FC-4732-9340-9FED051ED5EFQ36498827-E9263A24-5BD1-45A3-9F2C-9667550E0EFCQ36933835-34BBB01C-18E3-4AB5-986A-430D0D5CF0B8Q37174024-A6D923E8-47CF-4E1C-870D-7114639D74FAQ37529458-11C94744-4326-46E1-BB92-2E265388A911Q38388948-C812924D-E6FA-47DE-B7BC-C103E07858DAQ39252748-9A1D9334-F00D-4243-9C1F-6BF1FD27F69AQ40276044-7A5896A6-179C-4C5B-98B2-5B82426E76D2Q42598504-4F511C08-336F-40A7-B3FD-FD628B5DDFB5Q46407523-F021D5BE-C0B7-4374-85FB-B2700D1EF599Q53568732-9A8B9E1A-6545-4704-9AE0-6E82BAE350E3
P2860
Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Co-expression of CDX2 and MUC2 ...... ical parameters and prognosis.
@en
type
label
Co-expression of CDX2 and MUC2 ...... ical parameters and prognosis.
@en
prefLabel
Co-expression of CDX2 and MUC2 ...... ical parameters and prognosis.
@en
P2093
P2860
P356
P1476
Co-expression of CDX2 and MUC2 ...... ical parameters and prognosis.
@en
P2093
Arnulf-H Hölscher
Franz-Georg Hanisch
Hans-P Dienes
Juergen Thiele
Kristina Roessler
Paul-M Schneider
Stefan-P Mönig
Stephan-E Baldus
Stephanie Landsberg
P2860
P304
P356
10.3748/WJG.V11.I21.3182
P407
P577
2005-06-01T00:00:00Z